1. Clinical, biochemical, and genetic profile of an indian kindred with type 1 familial hypocalciuric hypercalcemia.
- Author
-
Alam, Sarah, Goyal, Alpesh, and Tandon, Nikhil
- Subjects
- *
CALCIUM metabolism , *HYPERCALCEMIA , *TYPE 2 diabetes - Abstract
Sir, Familial hypocalciuric hypercalcemia (FHH) is a rare genetic disorder with autosomal dominant inheritance and high penetrance that manifests with mild parathyroid hormone (PTH)-dependent hypercalcemia and hypocalciuria.[[1]],[[2]] The disorder results from an inherited defect in calcium sensing mechanism at the level of parathyroid gland and the thick ascending limb of loop of Henle of kidney.[[3]] FHH is genetically heterogenous and three subtypes have been described, namely, FHH1, FHH2, and FHH3, related to inactivating mutations in the genes encoding calcium sensing receptor (CaSR), G-protein subunit alpha-11 (GNA11), and adaptor-related protein complex 2 sigma 1 subunit (AP2S1) proteins, respectively.[[3]] Most patients with FHH are asymptomatic.[[4]] The disorder runs a benign course in most patients; parathyroidectomy is neither required, nor it is curative.[[5]] Symptoms of neonatal hypocalcemia have been described in unaffected children of women affected with this rare disorder.[[6]] Here, we describe an Indian kindred with genetically confirmed type 1 FHH where the presentation in the index case was delayed till the age of 48 years, and confounded by secondary hyperparathyroidism related to vitamin D deficiency. Given the biochemical picture of mild PTH-dependent hypercalcemia, hypocalciuria, and absence of any end-organ manifestations of PTH excess, we considered a possibility of FHH and requested for family biochemical screening. A further work-up of hypercalcemia was not done and the patient was administered calcium (1 gram per day elemental calcium) and injectable (cholecalciferol 600,000 IU intramuscular once a week for 2 weeks), followed by oral vitamin D (cholecalciferol 60,000 IU sachet once a week for 8 weeks) preparations. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF